Related Experiment Video
Updated: Jun 1, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Milestones in Parkinson's disease--clinical and pathologic features
Glenda Halliday1, Andrew Lees, Matthew Stern
1Neuroscience Research Australia and University of New South Wales, Sydney, Australia.
Summary
Parkinson's disease research has evolved beyond motor symptoms to explore diverse brain regions and phenotypes. New theories, including protein transmission, are paving the way for predicting and preventing preclinical Parkinson's disease.
Area of Science:
- Neuroscience
- Pathology
- Clinical Neurology
Background:
- Parkinson's disease (PD) conceptualization shifted significantly after identifying widespread fibrillized α-synuclein in Lewy bodies and neurites.
- The historical focus on dopaminergic nigrostriatal system loss and motor impairment has broadened to include diverse brain regions, symptoms, and phenotypes.
Observation:
- Parkinson's disease is now understood as more complex than just midbrain dopaminergic neuron loss and Lewy bodies.
- Emerging research investigates theories on disease development and progression, with a focus on cell-to-cell transmission of pathogenic proteins.
Findings:
- Recent advances allow for the prediction and clinical testing of preclinical Parkinson's disease signs and symptoms.
- The consensus definition of Parkinson's disease dementia facilitates determination of its pathological substrates.
Implications:
- Understanding the diverse pathology and preclinical stages of Parkinson's disease is crucial.
- Future strategies aim for early prediction and prevention of Parkinson's disease and its clinical manifestations.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...